Literature DB >> 29404772

Imaging prediction of nonalcoholic steatohepatitis using computed tomography texture analysis.

Shotaro Naganawa1, Kenichiro Enooku2, Ryosuke Tateishi2, Hiroyuki Akai3, Koichiro Yasaka3, Junji Shibahara4, Tetsuo Ushiku5, Osamu Abe1, Kuni Ohtomo6, Shigeru Kiryu7.   

Abstract

OBJECTIVES: To determine if texture analysis of non-contrast-enhanced CT (NECT) images is able to predict nonalcoholic steatohepatitis (NASH).
METHODS: NECT images from 88 patients who underwent a liver biopsy for the diagnosis of suspected NASH were assessed and texture feature parameters were obtained without and with filtration. The patient population was divided into a predictive learning dataset and a validation dataset, and further divided into groups according to the prediction of liver fibrosis as assessed by hyaluronic acid levels. The reference standard was the histological result of a liver biopsy. A predictive model for NASH was developed using parameters derived from the learning dataset that demonstrated areas under the receiver operating characteristic curve (AUC) of >0.65. The resulting model was then applied to the validation dataset.
RESULTS: In patients without suspected fibrosis, the texture parameter mean without filter and skewness with a 2-mm filter were selected for the NASH prediction model. The AUC of the predictive model for the validation dataset was 0.94 and the accuracy was 94%. In patients with suspicion of fibrosis, the mean without filtration and kurtosis with a 4-mm filter were selected for the NASH prediction model. The AUC for the validation dataset was 0.60 and the accuracy was 42%.
CONCLUSIONS: In patients without suspicion of fibrosis, NECT texture analysis effectively predicted NASH. KEY POINTS: • In patients without suspicion of fibrosis, NECT texture analysis effectively predicted NASH. • The mean without filtration and skewness with a 2-mm filter were modest predictors of NASH in patients without suspicion of liver fibrosis. • Hepatic fibrosis masks the characteristic texture features of NASH.

Entities:  

Keywords:  Computed tomography; Fatty liver; Hepatitis; Pattern recognition, Automated; Radiomics

Mesh:

Substances:

Year:  2018        PMID: 29404772     DOI: 10.1007/s00330-017-5270-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images.

Authors:  Weijie Chen; Maryellen L Giger; Hui Li; Ulrich Bick; Gillian M Newstead
Journal:  Magn Reson Med       Date:  2007-09       Impact factor: 4.668

2.  Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Ayako Suzuki; Paul Angulo; James Lymp; Dave Li; Shinji Satomura; Keith Lindor
Journal:  Liver Int       Date:  2005-08       Impact factor: 5.828

3.  Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.

Authors:  Hiroyuki Kaneda; Etsuko Hashimoto; Satoru Yatsuji; Katsutoshi Tokushige; Keiko Shiratori
Journal:  J Gastroenterol Hepatol       Date:  2006-09       Impact factor: 4.029

4.  Preliminary data using computed tomography texture analysis for the classification of hypervascular liver lesions: generation of a predictive model on the basis of quantitative spatial frequency measurements--a work in progress.

Authors:  Siva P Raman; James L Schroeder; Peng Huang; Yifei Chen; Stephanie F Coquia; Satomi Kawamoto; Elliot K Fishman
Journal:  J Comput Assist Tomogr       Date:  2015 May-Jun       Impact factor: 1.826

5.  Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis.

Authors:  Su Joa Ahn; Jung Hoon Kim; Sang Joon Park; Joon Koo Han
Journal:  Eur J Radiol       Date:  2016-08-23       Impact factor: 3.528

6.  Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Mariana Lazo; Ruben Hernaez; Mark S Eberhardt; Susanne Bonekamp; Ihab Kamel; Eliseo Guallar; Ayman Koteish; Frederick L Brancati; Jeanne M Clark
Journal:  Am J Epidemiol       Date:  2013-05-23       Impact factor: 4.897

7.  Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).

Authors:  Siddharth Verma; Donald Jensen; John Hart; Smruti R Mohanty
Journal:  Liver Int       Date:  2013-06-13       Impact factor: 5.828

Review 8.  Fat in the liver: diagnosis and characterization.

Authors:  Carlos Valls; Ricardo Iannacconne; Esther Alba; Takamichi Murakami; Masatoshi Hori; Roberto Passariello; Valérie Vilgrain
Journal:  Eur Radiol       Date:  2006-02-14       Impact factor: 5.315

9.  New clinical score to diagnose nonalcoholic steatohepatitis in obese patients.

Authors:  Fernanda Bu Pulzi; Raul Cisternas; Murilo R Melo; Cristiane Mf Ribeiro; Carlos A Malheiros; João E Salles
Journal:  Diabetol Metab Syndr       Date:  2011-02-23       Impact factor: 3.320

10.  Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity.

Authors:  Michael Pavlides; Rajarshi Banerjee; Elizabeth M Tunnicliffe; Catherine Kelly; Jane Collier; Lai Mun Wang; Kenneth A Fleming; Jeremy F Cobbold; Matthew D Robson; Stefan Neubauer; Eleanor Barnes
Journal:  Liver Int       Date:  2017-05-30       Impact factor: 5.828

View more
  15 in total

1.  Evaluation of renal dysfunction using texture analysis based on DWI, BOLD, and susceptibility-weighted imaging.

Authors:  Jiule Ding; Zhaoyu Xing; Zhenxing Jiang; Hua Zhou; Jia Di; Jie Chen; Jianguo Qiu; Shengnan Yu; Liqiu Zou; Wei Xing
Journal:  Eur Radiol       Date:  2018-12-17       Impact factor: 5.315

2.  Quality of science and reporting of radiomics in oncologic studies: room for improvement according to radiomics quality score and TRIPOD statement.

Authors:  Ji Eun Park; Donghyun Kim; Ho Sung Kim; Seo Young Park; Jung Youn Kim; Se Jin Cho; Jae Ho Shin; Jeong Hoon Kim
Journal:  Eur Radiol       Date:  2019-07-26       Impact factor: 5.315

3.  Imaging biomarkers of diffuse liver disease: current status.

Authors:  Bachir Taouli; Filipe Caseiro Alves
Journal:  Abdom Radiol (NY)       Date:  2020-06-25

4.  A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.

Authors:  Zhong-Wei Chen; Huan-Ming Xiao; Xinjian Ye; Kun Liu; Rafael S Rios; Kenneth I Zheng; Yi Jin; Giovanni Targher; Christopher D Byrne; Junping Shi; Zhihan Yan; Xiao-Ling Chi; Ming-Hua Zheng
Journal:  Hepatobiliary Surg Nutr       Date:  2022-04       Impact factor: 7.293

5.  Texture analysis of T2-weighted MRI predicts SDH mutation in paraganglioma.

Authors:  Shotaro Naganawa; John Kim; Stephen S F Yip; Yoshiaki Ota; Ashok Srinivasan; Toshio Moritani
Journal:  Neuroradiology       Date:  2020-11-19       Impact factor: 2.804

6.  Clinical-radiomics nomograms for pre-operative differentiation of sacral chordoma and sacral giant cell tumor based on 3D computed tomography and multiparametric magnetic resonance imaging.

Authors:  Ping Yin; Ning Mao; Sicong Wang; Chao Sun; Nan Hong
Journal:  Br J Radiol       Date:  2019-07-09       Impact factor: 3.039

7.  Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis.

Authors:  Pakanat Decharatanachart; Roongruedee Chaiteerakij; Thodsawit Tiyarattanachai; Sombat Treeprasertsuk
Journal:  Therap Adv Gastroenterol       Date:  2021-12-21       Impact factor: 4.409

Review 8.  Radiomics and Deep Learning: Hepatic Applications.

Authors:  Hyo Jung Park; Bumwoo Park; Seung Soo Lee
Journal:  Korean J Radiol       Date:  2020-04       Impact factor: 3.500

Review 9.  Radiomics in liver diseases: Current progress and future opportunities.

Authors:  Jingwei Wei; Hanyu Jiang; Dongsheng Gu; Meng Niu; Fangfang Fu; Yuqi Han; Bin Song; Jie Tian
Journal:  Liver Int       Date:  2020-07-02       Impact factor: 5.828

10.  Whole-liver histogram and texture analysis on T1 maps improves the risk stratification of advanced fibrosis in NAFLD.

Authors:  Xinxin Xu; Hong Zhu; Ruokun Li; Huimin Lin; Robert Grimm; Caixia Fu; Fuhua Yan
Journal:  Eur Radiol       Date:  2020-09-08       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.